Authors:
van Stolk, R
Stoner, G
Hayton, WL
Chan, K
DeYoung, B
Kresty, L
Kemmenoe, BH
Elson, P
Rybicki, L
Church, J
Provencher, K
McLain, D
Hawk, E
Fryer, B
Kelloff, G
Ganapathi, R
Budd, GT
Citation: R. Van Stolk et al., Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis, CLIN CANC R, 6(1), 2000, pp. 78-89
Citation: Ir. Schultz et Wl. Hayton, Interspecies scaling of the bioaccumulation of lipophilic xenobiotics in fish: An example using trifluralin, ENV TOX CH, 18(7), 1999, pp. 1440-1449